<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 and Chemotherapy as Adjuvant Treatment of Breast Cancer	</title>
	<atom:link href="https://9krapalm.com/alphamab-oncology-announces-the-first-patient-dosed-in-a-phase-iii-clinical-study-of-anbenitamab-kn026-combined-with-hb1801-and-chemotherapy-as-adjuvant-treatment-of-breast-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>https://9krapalm.com/alphamab-oncology-announces-the-first-patient-dosed-in-a-phase-iii-clinical-study-of-anbenitamab-kn026-combined-with-hb1801-and-chemotherapy-as-adjuvant-treatment-of-breast-cancer/</link>
	<description>เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm</description>
	<lastBuildDate>Tue, 24 Mar 2026 02:00:35 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>
</channel>
</rss>
